Company history

2010 ~ 2019

“ Korean Drug Co. Ltd is a company
that challenges the future with unprecedented growth and development

2019

Nov.

Designation as a company applying good manufacturing practice (GMP) for health functional food.

2016

Jul.

National research funding of KRW 550 million for development of new functional food ingredients in the use of Portulaca extracts.

2015

Nov.

Investment of 5% in share of "DIAMESCO Co, Ltd.', digital insulin pen development company.

Sept.

National research funding of KRW 1.2 billion for atopic dermatitis research.

2014

Jul.

Selection of the Agricultural biotechnology development business with utilizing common sage for osteoporosis treatment business, national research funding of KRW 5 billion